|
SMC4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.55679929953112E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.76429999685513E-08 |
| Normal-vs-Stage2 |
3.196700E-04 |
| Normal-vs-Stage3 |
1.17210000039059E-07 |
| Normal-vs-Stage4 |
7.12970005256608E-09 |
| Stage1-vs-Stage2 |
3.902000E-01 |
| Stage1-vs-Stage3 |
2.212800E-01 |
| Stage1-vs-Stage4 |
1.257540E-03 |
| Stage2-vs-Stage3 |
9.297800E-01 |
| Stage2-vs-Stage4 |
8.238100E-02 |
| Stage3-vs-Stage4 |
2.248100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.27480248579559E-11 |
| Normal-vs-AfricanAmerican |
2.678600E-03 |
| Normal-vs-Asian |
7.153200E-04 |
| Caucasian-vs-AfricanAmerican |
7.624900E-04 |
| Caucasian-vs-Asian |
5.500800E-01 |
| AfricanAmerican-vs-Asian |
2.675600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.14079975968673E-10 |
| Normal-vs-Female |
3.07689995704408E-09 |
| Male-vs-Female |
9.408600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.815520E-03 |
| Normal-vs-Age(41-60Yrs) |
1.50879975180374E-10 |
| Normal-vs-Age(61-80Yrs) |
6.5387999459432E-09 |
| Normal-vs-Age(81-100Yrs) |
1.660430E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.125400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.927000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.865900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.128000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.748290E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.011500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.698960E-03 |
| Normal-vs-Grade 2 |
1.94960000365896E-08 |
| Normal-vs-Grade 3 |
2.74410050238316E-10 |
| Normal-vs-Grade 4 |
2.7424000004217E-07 |
| Grade 1-vs-Grade 2 |
9.502000E-01 |
| Grade 1-vs-Grade 3 |
7.161600E-01 |
| Grade 1-vs-Grade 4 |
5.206200E-02 |
| Grade 2-vs-Grade 3 |
4.127400E-01 |
| Grade 2-vs-Grade 4 |
2.730000E-02 |
| Grade 3-vs-Grade 4 |
7.662600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.6016999948576E-08 |
| Normal-vs-ccB subtype |
3.12899994803217E-09 |
| ccA subtype-vs-ccB subtype |
3.888600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.31999974786845E-10 |
| Normal-vs-N1 |
4.796600E-04 |
| N0-vs-N1 |
2.861700E-02 |
|
|
